Adolor Reviews

Recommend to a friend
Approve of CEO
(no image)
Michael R. Dougherty
0 Ratings
  • Very professional entrepreneurial team

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Adolor


    Sale of Entereg to Michigan Health Systems- great product- strong pipeline


    bough by cubist pharmaceuticals December 2012

Adolor Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Exton, PA
Size 50 to 149 Employees
Founded Unknown
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

If you haven't got time for the pain, or for some of the unwanted side effects brought on by painkillers, Adolor hopes to help. In keeping with the movement toward improved pain management, the company is developing drugs that alleviate some of the side effects of certain pain treatments. Adolor's only marketed product, Entereg, is used as a treatment to aid in gastrointestinal (GI) recovery in patients following bowel resection surgery; the drug is designed to block the negative GI effects of opioids (like morphine) used to treat postoperative pain. Adolor was ... More

Work at Adolor? Share Your Experiences


Click to Rate